After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going in 2026?

Explore neuroscience breakthroughs reshaping treatments for Alzheimer’s, Parkinson’s, PTSD, and other brain disorders.

Explore 6 Maryland biotech companies with recent funding, ready to bring their breakthrough technologies to the clinic.

We examine Bristol Myers Squibb’s pipeline strategy and therapeutic priorities in 2026, as it faces a major patent cliff in ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...

The first cell rejuvenation therapy is set to enter clinics, testing if aging cells can be reset to a younger, healthier ...

Meet 5 hot biotechs in Arizona, from Phoenix to Tucson, that have raised significant funding over the past decade.

Learn about Carbios' story, as the French biotech focused on recycling polyethylene terephthalate (PET), faces pressure after ...

“Twenty years ago, or so, male infertility was not widely acknowledged or discussed. This reticence was driven by several factors – a lack of data highlighting prevalence of the problem, social stigma ...

Pfizer reaffirmed it is a household name through its partnership with BioNTech on the Pfizer-BioNTech COVID-19 vaccine, which received its first U.S. authorization from the Food and Drug ...

Over the past two decades, RNA interference (RNAi) has emerged as one of biotech’s most powerful approaches for precisely targeting disease at its genetic root. Unlike traditional drugs that act on ...